Zetolizumab (zenocutuzumab) price and purchase channels

Zenocutuzumab is a bispecific monoclonal antibody mainly used to treat patients with non-small cell lung cancer (NSCLC) and pancreatic cancer carrying NRG1 gene fusion. As of March 2025, zetolizumab has been approved in the United States to treat patients with the specific types of cancer listed above.

price information

At present, zetolizumab has not been approved for marketing in mainland China, so the domestic price information is not yet clear. In the United States, the price of biologics is usually higher, but specific pricing will vary depending on production costs, market demand, medical insurance coverage and other factors. Due to the lack of publicly available pricing information, patients or families are advised to contact the drug manufacturer directly or their local healthcare provider for the latest pricing information.

Purchase channels

Since zetolizumab has not yet been approved in mainland China, if patients need to use it, they may consider the following approaches:

International medical referral: Apply for international medical referral through formal medical institutions to receive treatment in countries that have approved the use of zetolizumab. This route requires considerations such as visas, medical costs and language.

Clinical trials: Pay attention to ongoing clinical trials at home and abroad. Some studies may recruit eligible patients to participate. Participation in a clinical trial may provide new treatment opportunities for patients, but the risks and benefits of the trial must be fully understood.

Overseas purchasing agency: seek overseas drug purchasing services through legal channels. It should be noted that unapproved drug purchasing may involve legal and safety risks, so it is recommended to choose carefully.

Things to note

Legality: Ensure that the selected channels comply with local laws and regulations to avoid getting into legal disputes.

Safety: Obtain drugs through formal channels to ensure the quality and efficacy of drugs.

Cost: Be financially prepared by considering the cost of treatment, travel costs, and other related expenses.

Since zetolizumab has not yet been approved for marketing in mainland China, patients need to obtain the drug through international medical referral, participation in clinical trials, or legal overseas purchasing. During this process, factors such as legality, safety, and cost should be fully considered to ensure the effectiveness and safety of the treatment.

Reference link: https://www.zailaboratory.com